Skip to main content

Table 6 Normal reference ranges for vital signs and safety assessments

From: A multi-centre, randomized, double-blind, placebo-controlled clinical trial of the efficacy and safety of chloroquine phosphate, hydroxychloroquine sulphate and lopinavir/ritonavir for the treatment of COVID-19 in Lagos State: study protocol for a randomized controlled trial

Parameter

Reference range

Temperature

36.1–37.2°C

Pulse rate

60–100 beats/min

Respiratory rate

12–16 cycles/min

Systolic blood pressure

90–130 mmHg

Diastolic blood pressure

70–90 mmHg

Haemoglobin

12–17.5 g/dl

White blood cell count

4.00–11.0 × 109/l

Platelet count

150,000–450,000/μl

Creatinine

0.5–1.1mg/dl

Random glucose

76–150mg/dl

Total bilirubin

0–1.0mg/dl

ALT

0–40u/l

AST

0–37i.u/l